Trevena, Inc. (NASDAQ: TRVN), today announced the outcome of the meeting of the U.S. Food and Drug Administration (FDA) Anesthetic ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot FDA News Management Comments Trading Halts

Trevena (TRVN) to Resume Trading at 5:40 pm ETOctober 11, 2018 5:28 PM Trevena Announces Oliceridine FDA Advisory Committee Meeting OutcomeOctober 11, 2018 5:04 PM Trevena's (TRVN) Pain-Killer Fails to Win FDA Backing, Panel Votes 8-7 Against Oliceridine - BloombergOctober 11, 2018 3:34 PM Trevena (TRVN) Reports FDA Advisory Committee to Review Oliceridine for Treatment of Moderate to Severe Acute PainOctober 11, 2018 7:08 AM Trevena Stock Trading Halted; FDA Advisory Committee to Review Oliceridine for the Treatment of Moderate to Severe Acute PainOctober 11, 2018 7:00 AM Trevena (TRVN) Halted, News PendingOctober 11, 2018 6:55 AM